Upneeq® is the only FDA-approved eye-lifting drop used to treat droopy eyelids (also known as blepharoptosis or ptosis). This medicine is a safe, temporary option for those who desire mild improvement but are not ready or are not a candidate for surgery. Upneeq® is distributed by RVL Pharmaceuticals, Inc.
Uses and Applications
Many adults suffer from drooping or sagging eyelids. The condition causes various symptoms including a decrease in our field of vision. In some cases, if left untreated, it can lead to lazy eye and permanently impair vision. Upneeq® was developed to reduce the sagging of your eyelids caused by many conditions including normal aging (the most common cause), cancer, stroke, tumors, Botox injections, and other medical issues, including Acquired Blepharoptosis (non-congenital drooping eyelids).
Featured and Benefits
Upneeq® eyedrops contain a 0.1% oxymetazoline hydrochloride ophthalmic solution. It’s packaged in a single-use vial that can be applied to the affected eye once a day. The active ingredient, oxymetazoline, stimulates the eyelid muscles. This causes the muscle to contract and raise the upper eyelid, so you can see better with less straining and squinting.
- Mild, Surgery-Free Eye Lift – opens eyes about 1-3 mm wider
- Quick Acting – it works as fast as 5 minutes with the first dose
- Lasting Treatment – your eyes stay uplifted at least 6 hours or more
- Safe and Well-Tolerated — can be applied 15 minutes before wearing contact lenses
How Upneeq® Compares to Alternative Treatments:
There are surgical treatments for ptosis. Upneeq® offers a non-surgical treatment solution without the risk of surgery or need for recovery time.
If you would like more information about this procedure you can make an appointment or contact the office for additional information.